Skip to content
lifestyle.ideacrossing.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Kailera Therapeutics, Inc.
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
June 5, 2026
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 26, 2026
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
May 24, 2026
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 21, 2026
Kailera Therapeutics Announces Pricing of Initial Public Offering
May 21, 2026
Kailera Therapeutics and Hengrui Pharma Report Positive Topline Data from Phase 2 Obesity Trial of Oral Ribupatide
February 12, 2026